NCM Capital Management LLC Acquires New Position in Colgate-Palmolive (NYSE:CL)

NCM Capital Management LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,956 shares of the company’s stock, valued at approximately $203,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Burney Co. raised its position in Colgate-Palmolive by 11.0% in the 1st quarter. Burney Co. now owns 21,813 shares of the company’s stock valued at $1,964,000 after purchasing an additional 2,160 shares in the last quarter. Cetera Investment Advisers raised its holdings in Colgate-Palmolive by 254.0% in the first quarter. Cetera Investment Advisers now owns 149,180 shares of the company’s stock valued at $13,434,000 after acquiring an additional 107,041 shares in the last quarter. Cetera Advisors LLC lifted its stake in Colgate-Palmolive by 105.3% in the first quarter. Cetera Advisors LLC now owns 49,362 shares of the company’s stock worth $4,445,000 after acquiring an additional 25,315 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in Colgate-Palmolive by 10.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 1,950 shares of the company’s stock worth $179,000 after acquiring an additional 177 shares in the last quarter. Finally, Mosaic Family Wealth Partners LLC purchased a new stake in shares of Colgate-Palmolive in the 1st quarter valued at approximately $206,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $96.60 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a market cap of $78.92 billion, a PE ratio of 27.68, a P/E/G ratio of 3.45 and a beta of 0.42. The stock has a fifty day moving average price of $97.38 and a 200 day moving average price of $98.58. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

CL has been the subject of a number of analyst reports. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. UBS Group upped their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. TD Cowen lowered their price target on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price objective on the stock. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.